Nutrition 21 has launched a new beauty-from-within ingredient backed by a recent clinical study that the company believes will help to further enlarge a category that after many false starts finally seems to be in a solid growth phase.
A new paper authored by experts in creatine supplementation seeks to dispel some long standing misconceptions about this legacy sports nutrition ingredient. Among the concerns addressed are water retention, kidney damage, baldness and others.
The study marks the first time humans were included in a peer-reviewed investigation of commercially available CBD product pharmacokinetics. Previous CBD studies have generally based their claims on animal model studies.
Guelph-based Nutrasource Pharmaceutical and Nutraceutical Services has received approval for an official Institution-Wide Cannabis Research License, paving the way for human research on cannabis and cannabis-derived compounds.
The manufacturer of a glutathione supplement has agreed to cease certain health and performance claims associated with the product after a ruling by the National Advertising Division.
Can the First Amendment shield a publisher of supposedly independent product reviews if it has secretly rigged the ratings in favor of one company in exchange for compensation? According to a recent decision, this speech qualifies as commercial speech.
Federal Trade Commission Chairman Joseph Simons announced his resignation yesterday, which begins the process of filling slots at the commission with Biden Administration appointees. A reformed FTC is likely to take a stronger line on consumer protection,...
An industry watchdog group flagged coronavirus treatment claims being made by a multilevel marketing company and has referred the matter to the Federal Trade Commission.
Supplement manufacturer Zarbee’s Naturals has been advised to qualify some of its claims in a National Advertising Division case that bears on the question of what is meant by the term ‘natural.’
French authorities have highlighted the need to take precautions when taking food supplements containing tea tree, niaouli and cajeput essential oils, citing risks to children, pregnant or breastfeeding women resulting from their misuse.
Companies advertising their dietary supplement products in New Zealand should avoid pitfalls such as making therapeutic claims, using imagery that implies therapeutic purposes, or overpromising a health outcome.
